Drug Trial Radar · NCT01631474
A Phase 2 Dose Escalating Study to Evaluate the Safety and Efficacy of CB-03-01 Cream in Subjects With Facial Acne Vulgaris
Last checked: Nov 19, 2026Latest source record: Nov 16, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
363
Actual
Start
Jun 2012
Primary completion
Feb 2014
Study completion Feb 2014
Sponsor
- Lead sponsor
- Intrepid Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jun 29, 2012
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
CB-03-01 is being developed for the topical treatment of acne vulgaris, an androgen-dependent skin disorder. The purpose of this study is to compare the safety and efficacy of multiple concentrations of CB-03-01 to vehicle in the treatment of acne vulgaris.
Conditions
- Acne Vulgaris
Interventions
CB-03-01Drug
Topical cream, applied once a day
VehicleDrug
Topical cream, applied once or twice a day
CB-03-01Drug
Topical cream, applied twice a day
Primary outcomes
What the sponsor says the trial is designed to measure.
- Investigator's Global Assessment (IGA) "Success" - Week 12Time frame: Baseline and Week 12
- Inflammatory and Non-Inflammatory Lesion Counts - Week 12Time frame: Baseline and Week 12
Locations
13 sites in 1 country. Site status is shown where the registry gives one.
Dermatology Research Associates
Los Angeles, California
Therapeutics Clinical Research
San Diego, California
University Clinical Trials
San Diego, California
International Clinical Research - US, LLC
Sanford, Florida
Gwinnett Clinical Research Center, Inc.
Snellville, Georgia
Altman Dermatology Associates
Arlington Heights, Illinois
Indiana Clinical Trials Center
Plainfield, Indiana
Marina I. Peredo, M.D., PC
Smithtown, New York
Penn State Milton S. Hershey Medical Center - Dept. of Dermatology
Hershey, Pennsylvania
Clinical Partners, LLC
Johnston, Rhode Island
J & S Studies
College Station, Texas
UT Houston Health Science Center
Houston, Texas
Virginia Clinical Research
Norfolk, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.